Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen.
about
Early detection of hepatitis C virus infection by use of a new combined antigen-antibody detection assay: potential use for high-risk individuals.Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection.Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings.Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patientsHCV core antigen and HCV-RNA in HIV/HCV co-infected patients with different HCV genotypes.Kinetics and significance of serum hepatitis C virus core antigen in patients with acute hepatitis CMolecular and contextual markers of hepatitis C virus and drug abuse.Japanese reference panel of blood specimens for evaluation of hepatitis C virus RNA and core antigen quantitative assaysThe laboratory diagnosis of hepatitis B virus.Important factors in reliable determination of hepatitis C virus genotype by use of the 5' untranslated regionHepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction.Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV).Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test.Evaluation of the core antigen assay as a second-line supplemental test for diagnosis of active hepatitis C virus infection.Hepatitis C core Ag and its clinical applicability: potential advantages and disadvantages for diagnosis and follow-up?A novel antigen detection immunoassay for field diagnosis of hepatitis C virus infection.Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome.Evaluation of five screening tests licensed in Argentina for detection of hepatitis C virus antibodies.Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection.Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system.Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy.De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.Hepatitis C core antigen in Polish blood donors.Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors.Recommendations on hepatitis C screening for adults.New tools in HCV diagnosis, in light of the enhanced awareness and the new drugs for treatment: SMARTube and stimmunology
P2860
Q27473162-DF34423B-A780-4D47-AB24-1D89F1662DD3Q30434900-32C40EDC-6547-4DEC-A33B-D7DBC5340499Q33450364-0E5EE05F-9924-49A3-A6B4-C534C843320AQ33592762-5A92CEBF-2D79-4F5D-9CDF-93101E516E9FQ33645428-89689477-9828-48A8-87F4-9CDA4413CED5Q34991008-15493C84-73AC-4375-8924-6A6B8ED9744BQ35660841-968D07C1-20E5-4B69-8910-9BD20AD9DA19Q36022842-32A86457-58DD-4DCF-A691-33E8B7F7FABAQ36171000-360F0799-A45D-449D-BEE6-B997538E8470Q36826804-0D25F174-20B7-4B84-820C-F50F614D1DA8Q37158806-797FDE9C-72ED-4C50-A4B8-2C7FA1F2DF4FQ37183997-A7BE8FB8-123E-460B-B25D-D051BC5F6EBAQ37296858-27E045A4-9C7D-4C41-B6AD-91693ADD2D81Q37511219-83B1E203-6327-4D98-9C8F-640A4650C87DQ37961619-BC103BD0-CEA1-49E2-82C3-B23A8FB01310Q38883263-BFB46F95-9EE9-4E32-8C83-D2C6737A3E0AQ40938343-A573E10C-4EEA-411C-82DF-2F6772CD4BDEQ42994597-07CF2F9F-CD60-4C94-BFB9-9E0E8A2FA8E7Q42997213-81E67EE6-DC6F-416D-BA5E-CDC727B95EE6Q43031733-C26FD084-2483-4FC2-B40C-86A1104E1553Q43042208-1D6FF63C-332C-4DA2-8454-2FFC4733D151Q43049351-1F5FE802-FA41-4F01-9359-5FCA6A081F99Q46414212-91B2DF5A-384B-43D9-9F5B-3E0550E5798EQ47269593-401E6AFE-D663-4433-8E2B-13B599B283A3Q50750366-7FDB8B23-1760-40B1-B9F3-8BD95F073FE0Q53836297-3F79D469-D673-490D-AA1D-E1B54F39E296Q56916502-7AA09F85-FAA8-4D70-B6A0-59DA932DF235
P2860
Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Novel approach to reduce the h ...... nt assay for HCV core antigen.
@en
Novel approach to reduce the hepatitis C virus
@nl
type
label
Novel approach to reduce the h ...... nt assay for HCV core antigen.
@en
Novel approach to reduce the hepatitis C virus
@nl
prefLabel
Novel approach to reduce the h ...... nt assay for HCV core antigen.
@en
Novel approach to reduce the hepatitis C virus
@nl
P2093
P2860
P1476
Novel approach to reduce the h ...... nt assay for HCV core antigen.
@en
P2093
B M Bruzzone
C de Luigi
P2860
P304
P356
10.1128/JCM.39.9.3110-3114.2001
P407
P577
2001-09-01T00:00:00Z